Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aditxt Inc
(NQ:
ADTX
)
0.8976
-0.0524 (-5.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aditxt Inc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 24, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
February 24, 2023
It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on!
Via
InvestorPlace
Consuming Too Much Salt May Trigger Autoimmune Illnesses
February 22, 2023
Via
Investor Brand Network
TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms US-Based Subsidiary with Focus to Expand Innovation Platforms
February 14, 2023
Via
Investor Brand Network
Research Explains Why MS Patients Benefit from Stem Cell Transplants
November 16, 2022
Via
Investor Brand Network
Why Food Allergies May Be Increasing
October 28, 2022
Via
Investor Brand Network
Aditxt Forms its Second Subsidiary, Pearsanta, Inc., to Accelerate the Growth of its AditxtScore™ Program and Appoints Healthcare Executive and Current Head of AditxtScore™ Anthony Voorhies to Serve as its President
February 14, 2023
From
Aditxt, Inc.
Via
Business Wire
Food Allergies Worsen Cost of Living for Impacted Individuals
February 08, 2023
Via
Investor Brand Network
Topics
Economy
Exposures
Interest Rates
Supply Chain
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Reaches Pivotal Milestone to Advance ADI (TM) Technology
January 20, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Dedicated to New Era of Precision Medicine
January 11, 2023
Via
Investor Brand Network
Aditxt, Inc. (NASDAQ: ADTX) Bolsters Goal to Conduct First-In-Human Clinical Trial Evaluating ADI(TM) Tech with Formation of Adimune, Inc. Subsidiary; Appoints Industry Veteran as Subsidiary Chairman and CEO
January 10, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms Subsidiary with Focus on Immune Modulation Therapies
January 03, 2023
Via
Investor Brand Network
Aditxt Forms Adimune, Inc. as a Wholly Owned Subsidiary with a Focus on Immune Modulation Therapies and Appoints Dr. Friedrich Kapp, Former President of the Therapeutic Business Unit at Schering AG, as its Chairman and CEO
January 03, 2023
From
Aditxt, Inc.
Via
Business Wire
Aditxt Inc. (NASDAQ: ADTX) Announces Goal of First-in-Human Trials for Drug Candidate ADI(TM)-100 with a Focus on Psoriasis
December 28, 2022
Via
Investor Brand Network
Researchers Look to AI to Improve Organ Transplant Processes
November 30, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Equity Research Reports
November 28, 2022
Via
Investor Brand Network
Exposures
COVID-19
Department of Defense Awards Scientists at University of Buffalo $4M Grant to Study Concussion Treatment
November 23, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
November 18, 2022
Via
Benzinga
Genes That Saved People from Bubonic Plague Linked to Autoimmune Conditions Today
November 11, 2022
Via
Investor Brand Network
Research Finds That Stem Cells Reduce Lung Transplant Rejection Rates
November 03, 2022
Via
Investor Brand Network
Study Finds Livers with a Cumulative Age of 100 Years
October 21, 2022
Via
Investor Brand Network
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
During Monday's session, 96 stocks hit new 52-week lows.
Via
Benzinga
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Key Milestone in Advancing Adimune(TM) Program
October 21, 2022
Via
Investor Brand Network
Aditxt’s (Nasdaq: ADTX) Adimune™ Program Has Initiated the Manufacturing Process of Immunotherapeutic Drug Candidate, ADI™-100 in Preparation for Planned Psoriasis First-in-Human Trials
October 21, 2022
From
Aditxt, Inc.
Via
Business Wire
Allergies: How They Occur and Why They Sometimes Disappear
October 14, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Publication of Innovative Mathematical Model
October 12, 2022
Via
Investor Brand Network
Exposures
COVID-19
Aditxt, Inc. (Nasdaq: ADTX) Announces Development and Publication of a Mathematical Model for Predicting Longevity and Variations of Immune Response to Immunization to SARS-CoV-2 Infection
October 12, 2022
From
Aditxt, Inc.
Via
Business Wire
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
October 10, 2022
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 07, 2022
Gainers Inventiva (NASDAQ:IVA) shares increased by 44.0% to $5.88 during Friday's regular session. The market value of their outstanding shares is at $247.6 million.
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session
October 07, 2022
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.